Roche 2022: Portfolio renewalIssue Archives, October 2022, TherapeuticsA strong product pipeline and increased group sales confirm that Roche is on the right growth path. Read more October 11, 2022/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2022/10/Roche-rapid-antigen-test.jpeg 434 650 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2022-10-11 01:00:022022-10-04 16:16:04Roche 2022: Portfolio renewal
